Finished dosage facility of Granules in Hyderabad gets 11 U.S. FDA observations

🇮🇳 The Hindu (IN) —
Finished dosage facility of Granules in Hyderabad gets 11 U.S. FDA observations

AI Summary

A finished-dosage manufacturing facility operated by Granules in Hyderabad received 11 observations from the U.S. Food and Drug Administration. The FDA had issued a warning letter in February 2025 following an inspection conducted in August and September 2024.

The U.S. FDA issued a warning letter in February 2025 after inspecting the facility in August–September 2024

World Markets Health Granules FDA observations pharmaceuticals drug manufacturing Hyderabad warning letter regulatory compliance

Read original source →